Landscapes / Targets
THR-beta
5 drugs act on THR-beta, in 14 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Thyroid hormone receptor beta (THR-β) agonist |
Madrigal Pharmaceuticals · Public MDGL |
Approved | Dec 2026Phase 3 trial completes | ||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | MASH - Metabolic Dysfunction-Associated Steatohepatitis, NASH - Nonalcoholic Steatohepatitis and 5 more | ||||
| Open drug page | |||||
Thyroid hormone receptor beta agonist |
Approved in UK | — | |||
| How it works | Acts like thyroid hormone | ||||
| Also tested for | MASH - Metabolic Dysfunction-Associated Steatohepatitis | ||||
| Open drug page | |||||
— |
Phase 2 | 15 Aug 2027Phase 2 trial completes | |||
| Next date | 15 Aug 2027 · Phase 2 trial completes | ||||
| Also tested for | Metabolic Dysfunction-Associated Steatoic Liver Disease | ||||
| Open drug page | |||||
THR-beta agonist unconfirmed |
Phase 2 | 15 Sep 2027Phase 2 trial completes | |||
| How it works | Acts like thyroid hormone | ||||
| Next date | 15 Sep 2027 · Phase 2 trial completes | ||||
| Also tested for | Metabolic Dysfunction-associated Steatohepatitis, Adult Obesity and 3 more | ||||
| Open drug page | |||||
— |
Phase 1 | Mar 2027Phase 1 trial completes | |||
| Next date | Mar 2027 · Phase 1 trial completes | ||||
| Also tested for | Overweight and Obesity | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 5 of 5 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026